VIVO and CB2 Insights Enter Technology and Research Partnership
29 oct. 2019 07h48 HE
|
CB2 Insights
Partnership to focus on implementing a medical product development strategy for VIVO’s global medical cannabis offering, utilizing CB2 Insights’ leading technology platform Sail and research...
Aldevron Names Diane Rogers as Senior Vice President Commercial Development
09 oct. 2019 15h46 HE
|
Aldevron
Fargo, North Dakota, Oct. 09, 2019 (GLOBE NEWSWIRE) -- Diane Rogers has joined Aldevron as its Senior Vice President Commercial Development. In her role, Rogers will be responsible for leading the...
Abeona Therapeutics to Host R&D Day on December 6, 2018
29 nov. 2018 08h45 HE
|
Abeona Therapeutics Inc.
NEW YORK and CLEVELAND, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene...
Abeona Therapeutics Announces Leadership Appointments with Max Colao as Chief Commercial Officer
26 juil. 2018 08h30 HE
|
Abeona Therapeutics Inc.
NEW YORK and CLEVELAND, July 26, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene...
Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT Meeting
18 mai 2018 09h25 HE
|
Abeona Therapeutics Inc.
ABO-102 18-month efficacy and safety data continue to demonstrate time- and dose-dependent reductions in underlying disease pathology, including decreased CSF and urine GAGs and improved liver...
Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
02 avr. 2018 08h15 HE
|
Abeona Therapeutics Inc.
Company strengthens management team with biopharmaceutical veteran bringing extensive commercial experience in life-threatening rare diseases Tim Miller, Ph.D. continues as president and assumes chief...
Abeona Therapeutics Reports Fourth Quarter 2017 Financial Results and Business Highlights
16 mars 2018 17h10 HE
|
Abeona Therapeutics Inc.
NEW YORK and CLEVELAND, March 16, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and...
Record Attendance! Over 1,800 Clinical Ops Executives Attending SCOPE Summit in Orlando, FL
09 févr. 2018 15h37 HE
|
Cambridge Healthtech Institute
NEEDHAM, MA--(Marketwired - February 09, 2018) - Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, announces agenda updates and special events planned for the Ninth...
Abeona Therapeutics Reports on Initial Safety and Biopotency Signals in MPS IIIB Gene Therapy Clinical Trial
07 févr. 2018 08h45 HE
|
Abeona Therapeutics Inc.
First-in-man AAV9-based gene therapy delivered by single intravenous injection targeting central nervous system and peripheral manifestations of MPS IIIB.ABO-101 is well tolerated and demonstrates...
Abeona Enrolls First Subject in Spain in Ongoing Phase 1/2 Clinical Trial in MPS IIIA
09 nov. 2017 08h45 HE
|
Abeona Therapeutics Inc.
Company Opens European Subsidiary in Spain to Support Global Clinical DevelopmentNine subjects at global clinical sites enrolled to date with more than 2,000 days cumulative follow up assessed NEW...